BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 6713337)

  • 1. Nitrofurantoin-induced agranulocytosis.
    Lopes V; Ramos J; Dias P; Santos A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone-induced agranulocytosis: a case report.
    Hsiao SH; Lin YJ; Hsu MY; Wu TJ
    Kaohsiung J Med Sci; 2003 Nov; 19(11):574-8. PubMed ID: 14658487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentazocine-induced agranulocytosis.
    Haibach H; Yesus YW; Doggett JJ
    Can Med Assoc J; 1984 May; 130(9):1165-6. PubMed ID: 6713337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentazocine-induced agranulocytosis.
    Sheehan M; Hyland RH; Norman C
    Can Med Assoc J; 1985 Jun; 132(12):1401. PubMed ID: 4005730
    [No Abstract]   [Full Text] [Related]  

  • 5. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications of G-CSF in patients with drug-induced agranulocytosis].
    Takeda R; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Kuriya S
    Rinsho Ketsueki; 1993 Sep; 34(9):997-1001. PubMed ID: 7693988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentazocine and agranulocytosis.
    Marks A; Abramson N
    Ann Intern Med; 1980 Mar; 92(3):433. PubMed ID: 7356240
    [No Abstract]   [Full Text] [Related]  

  • 8. Granulocytopenia after intravenous abuse of pentazocine and tripelennamine ("Ts and blues").
    Heaney RM; Gotlieb N
    South Med J; 1983 May; 76(5):654-6. PubMed ID: 6844971
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal pancytopenia after administration of Fortagestic.
    Datta SB
    Br Med J; 1973 Jul; 3(5872):173. PubMed ID: 4720777
    [No Abstract]   [Full Text] [Related]  

  • 10. Pentazocine: a review of its pharmacological properties, therapeutic efficacy and dependence liability.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1973; 5(1):6-91. PubMed ID: 4578369
    [No Abstract]   [Full Text] [Related]  

  • 11. Agranulocytosis secondary to pentazocine therapy.
    Hoppin EC; Greenberg BR; Walter RM
    Arch Intern Med; 1978 Apr; 138(4):533-4. PubMed ID: 637634
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.